Food Supplements Containing Botanicals: Benefits, Side Effects and Regulatory Aspects 2017
DOI: 10.1007/978-3-319-62229-3_2
|View full text |Cite
|
Sign up to set email alerts
|

The Regulatory Situation in Europe and Other Continents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…In a Regulatory Affairs Report from 2018, Coppens states: "After the adoption of the Food Supplements Directive 2002/46, the Commission published a report in 2008 on further harmonization in this area" (Commission of the European Communities, 2008). He concluded that harmonization would be difficult to achieve given the different positions of the Member States and the scientific issues that must first be resolved (Coppens, 2018). Member States with undefined maximum levels feared that EU harmonization would limit their market (Government of the UK, Expert Group on Vitamins and Minerals, 2003).…”
Section: Intake Of Vitamin E Through Supplementationmentioning
confidence: 99%
“…In a Regulatory Affairs Report from 2018, Coppens states: "After the adoption of the Food Supplements Directive 2002/46, the Commission published a report in 2008 on further harmonization in this area" (Commission of the European Communities, 2008). He concluded that harmonization would be difficult to achieve given the different positions of the Member States and the scientific issues that must first be resolved (Coppens, 2018). Member States with undefined maximum levels feared that EU harmonization would limit their market (Government of the UK, Expert Group on Vitamins and Minerals, 2003).…”
Section: Intake Of Vitamin E Through Supplementationmentioning
confidence: 99%
“…In fact, their use can enter into conventional medicine, or, as in some European countries (e.g., Germany), in "Traditional Herbal Medicinal Products (THMPs)". THMPs must guarantee their safety in the expected conditions of use and their biological activity/efficacy must be plausible on the basis of a chronic use and of available experience [10].…”
Section: Other Categoriesmentioning
confidence: 99%